Data updated: Nov 8, 2026
BICILLIN (penicillin g benzathine) · Pfizer
Infectious Disease
Approved 1951-11-22
1
Indication
--
Phase 3 Trials
74
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1951-11-22
- Revenue
- $24M (Q4-2023)
- Routes
- ORAL
- Dosage Forms
- SUSPENSION, TABLET
BICILLIN Approval History
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
1 FDA actions from 1951 to 1951
Nov 1951 ORIGINAL
Update
What BICILLIN Treats
1 FDA approvalsOriginally approved for its first indication in 1951 .
- Other (1)
Other
(1 approval)- • Approved indication (Nov 1951)
Pfizer's other novel FDA approvals
Other CDER-designated drugs from the same sponsor (2016–2025).
HYMPAVZI
2024 MARSTACIMAB-HNCQ
2 designations
ZAVZPRET
2023 ZAVEGEPANT HYDROCHLORIDE
NGENLA
2023 SOMATROGON-GHLA
1 designation
VELSIPITY
2023 ETRASIMOD ARGININE
PAXLOVID (COPACKAGED)
2023 NIRMATRELVIR
3 designations
LITFULO
2023 RITLECITINIB TOSYLATE
ELREXFIO
2023 ELRANATAMAB
5 designations
CIBINQO
2022 ABROCITINIB
2 designations
NURTEC ODT
2020 RIMEGEPANT SULFATE
VIZIMPRO
2018 DACOMITINIB
2 designations
DAURISMO
2018 GLASDEGIB MALEATE
2 designations
TALZENNA
2018 TALAZOPARIB TOSYLATE
1 designation
📋
Clinical Trial Registry
1 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT03612557 | B8441001 | Ph 1 | completed | A Study of Benzathine Benzylpenicillin Intramuscular Injection in Japanese Healthy Subjects |
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
|
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
BICILLIN FDA Label Details
Pro Intelligence Preview
Deep insights for BICILLIN
Revenue Insights
- • Q4-2023: $24M
- • Historical trend analysis
Patent Timeline
- • Patent expiration dates
- • Generic/biosimilar risk
Trial Analysis
- • Clinical trial tracking
- • Development stage analysis
Competitive Landscape
- • Competitor tracking
- • Same target/indication analysis
Unlock Full Intelligence
Full approval history • All patents • Revenue trends • Competitor analysis
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.